Leveraging Medical Affairs Preliminary Feasibility Assessments to Successfully Identify Centers of Excellence That Strengthen Gene Therapy Clinical Programs

Time: 11:20 am
day: Day One


  • Uncover how MSL’s are engaging KOLs early to help determine institutional gene therapy trial capabilities and capacity
  • Explore the role of field medical affairs in assisting Clinical Operations in securing potential clinical trial sites
  • Discuss how clinical insights from KOLs are shared internally to support Clinical Development in trial design and execution